: MedTech Funding: Insights from VC expert Katleen Vandersmissen from Heran Partners 

investor
co:lab podcast logo

In this episode of the co:lab podcast, we sit down with Katleen Vandersmissen, Managing Partner at Heran Partners, to explore what it takes to build and scale successful startups in MedTech and HealthTech.

blue dots of co:lab

With extensive experience in early-stage venture capital, Katleen shares practical advice for entrepreneurs, from identifying unmet market needs to crafting an investment case that attracts funding. She highlights the critical role of AI, data, and innovation in shaping the future of healthcare, while also tackling the challenges of regulation and how startups can turn them into competitive advantages.

Drawing from her own career journey, from a scientific background to leading a top venture capital fund, Katleen offers insights on how founders can effectively structure their cap tables, build strong investor relationships, and leverage corporate partnerships for growth.

This episode is a must-listen for entrepreneurs, investors, and innovators looking to navigate the complex world of startup funding and venture capital. Whether you’re seeking to secure funding, scale a healthcare startup, or understand what VCs are really looking for, this conversation provides a roadmap to success.

other podcasts

photo of Nico Huybrechts during co:lab podcast
Season 2 Episode 8
Scaling Datashift: Nico Huybrechts on Growth, Governance and AI 
In the final episode of this co:lab season, we sit down with Nico Huybrechts, founder and CEO of Datashift. Ten years ago, Datashift started at the kitchen table. Today, it is a multidisciplinary data & AI consultancy operating across borders. But this conversation goes beyond numbers.
podcast colab ep.7 - Leen Limbourg
Season 2 Episode 7
How life sciences innovation survives uncertainty with investor Leen Limbourg
In this episode of co:lab, we speak with Leen Limbourg, medical doctor, investor and experienced board member, about the realities of building and funding life sciences companies in today’s challenging environment.